OverviewChartNewsTraderScreen

Cognition Therapeutics/  US19243B1026  /

IEX
21/05/2024  21:58:27 Chg. +0.13 Volume Bid- Ask- High Low
2.26USD +6.12% 1,544
Turnover: 3,424.74		 -Bid Size: - -Ask Size: - 2.26 2.12
GlobeNewswire 21/05 Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from ...
GlobeNewswire 07/05 Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Up...
GlobeNewswire 29/04 Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate D...
GlobeNewswire 22/04 Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Op...
GlobeNewswire 02/04 Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
GlobeNewswire 01/04 Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on...
GlobeNewswire 26/03 Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
GlobeNewswire 15/03 Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
GlobeNewswire 14/03 Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
GlobeNewswire 12/03 Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
GlobeNewswire 11/03 Cognition Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire 06/03 Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatmen...
GlobeNewswire 26/02 Cognition Therapeutics to Present at the TD Cowen Health Care Conference
GlobeNewswire 06/02 New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism ...
GlobeNewswire 04/01 Cognition Therapeutics CEO Issues Letter to Shareholders
GlobeNewswire 16/11/2023 Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantit...
GlobeNewswire 15/11/2023 Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor M...
GlobeNewswire 07/11/2023 Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alz...
GlobeNewswire 02/11/2023 Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 27/10/2023 Cognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation o...
GlobeNewswire 24/10/2023 Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderat...
GlobeNewswire 16/10/2023 Cognition Therapeutics Presents New Data at CTAD Conference from Advancing Pipeline Across Multiple ...
GlobeNewswire 07/09/2023 Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the ...
GlobeNewswire 30/08/2023 Cognition Therapeutics Announces Participation in Upcoming September Conferences
GlobeNewswire 29/08/2023 Faron Reports Half-Year Financial Results, January 1 – June 30, 2023